Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05540561

Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Biological Alterations of Laughing Gas Outcomes in Neurology

Status
Recruiting
Phase
Study type
Observational
Enrollment
356 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
14 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There is a toxicity linked to the chronic use of nitrous oxide, leading to neurological disorders such as combined sclerosis of the spinal cord. One thus frequently observes patients presenting disorders of walking or paresthesias, of more or less resolving evolution being able to go until the need for using a wheelchair and more recently cases of thrombosis were reported Serum or urine N2O assays are rarely performed routinely, because they do not allow to ensure a real exposure due to the very short half-life of this gas in the body. Thus, other biological monitoring markers are mentioned in the literature, such as vitamin B12 or homocysteine. Unfortunately, there are still no recommendations for biological monitoring of nitrous oxide consumption. Moreover, underlying mechanisms leading to clinical outcomes remains misunderstood.

Conditions

Interventions

TypeNameDescription
OTHERblood collectionBiological analyses in the framework of care with conservation of blood samples

Timeline

Start date
2023-01-30
Primary completion
2025-01-30
Completion
2025-01-30
First posted
2022-09-14
Last updated
2024-10-26

Locations

8 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05540561. Inclusion in this directory is not an endorsement.